Advertisement

Topics

Baxter Completes $625M Purchase of Claris Injectables

06:52 EDT 31 Jul 2017 | Contract Pharma

Broadens Baxter’s presence in the generic pharmaceuticals space

Original Article: Baxter Completes $625M Purchase of Claris Injectables

NEXT ARTICLE

More From BioPortfolio on "Baxter Completes $625M Purchase of Claris Injectables"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...